Table 3.
Clinical Response (PPC) by Infecting Organism at End of Treatment (Day 8)1
| Infecting Organism(s) | |||||
|---|---|---|---|---|---|
| Treatment Dose | S. aureus (MSSA) (n=89) | S. aureus (MRSA) (n=9) | S. pyogenes (n=7) | S. aureus (MSSA) andS. pyogenes (n=11) | S. aureus (MRSA) andS. pyogenes (n=1) |
| NVC-422 | 22/27 | 4/4 | 4/4 | 3/4 | N/A |
| 0.1% | (81%) | (100%) | (100%) | (75%) | |
| NVC-422 | 29/34 | 2/2 | 3/3 | ||
| 0.5% | (85%) | (100%) | (100%) | N/A | N/A |
| NVC-422 | 26/28 | 3/3 | N/A | 6/7 | 1/1 |
| 1.5% | (93%) | (100%) | (86%) | (100%) | |
1
N/A denotes organisms were not present in these groups at baseline.